Zosano pharma corp (ZSAN)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14
ASSETS
Current assets:
Cash and cash equivalents

18,557

6,316

6,492

14,252

6,142

9,140

11,962

16,197

3,537

11,651

13,292

21,159

37,341

15,003

19,178

10,057

6,561

6,646

4,875

8,060

55,917

1,214

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

24

142

111

Interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29

54

73

101

84

100

-

0

Marketable securities at fair value

-

-

0

3,488

4,896

13,862

17,514

21,441

-

0

6,557

7,066

-

-

3,878

12,839

21,807

30,287

34,098

28,593

-

0

Prepaid expenses and other current assets

623

497

779

991

921

358

1,069

869

1,970

1,742

1,335

1,166

762

273

412

581

1,456

237

459

861

733

311

Total current assets

19,180

6,813

7,271

18,731

11,959

23,360

30,545

38,507

5,507

13,393

21,184

29,391

38,103

15,276

23,497

23,531

29,897

37,271

39,516

37,638

56,792

1,636

Restricted cash

455

500

455

500

500

455

35

35

35

500

35

35

35

35

35

35

35

35

35

35

35

35

Long-term investments in marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,923

13,949

-

-

Property and equipment, net

30,164

24,636

22,936

20,568

16,869

11,916

7,620

6,132

4,410

4,152

4,240

4,798

4,904

5,455

6,107

6,710

7,242

7,660

8,036

8,507

9,106

9,681

Operating lease right-of-use assets

5,533

5,763

5,985

6,016

6,219

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

3

3

21

17

21

49

655

552

420

0

420

420

140

140

388

384

373

371

513

510

496

1,991

Total assets

55,335

37,670

36,668

45,787

35,523

35,780

38,855

45,226

10,372

18,000

25,879

34,644

43,182

20,906

30,027

30,660

37,547

45,337

53,023

60,639

66,429

13,343

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

3,263

4,356

3,811

5,985

3,678

4,450

1,205

2,391

2,421

1,511

1,074

1,208

907

1,445

1,692

887

1,403

1,209

2,036

1,797

1,208

1,447

Accrued compensation

2,553

2,015

1,836

1,459

2,742

2,092

1,733

1,434

2,099

1,571

1,304

1,146

1,419

1,377

1,162

1,202

1,402

1,275

1,257

829

535

1,676

Long-term Debt, Current Maturities

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

62

-

-

-

-

-

-

-

-

-

-

0

0

68

170

Related parties convertible notes (including accrued interest)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

7,362

Secured promissory note (including accrued interest), net of issuance costs

-

-

-

-

-

-

0

3,600

5,160

6,687

6,229

6,118

6,106

5,992

5,931

6,247

4,793

3,360

1,958

0

1,457

1,408

Build-to-suit obligation, current portion

4,665

4,554

3,917

3,147

2,451

2,326

1,336

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, current portion

1,184

1,140

1,096

1,026

985

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Freestanding warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

300

Other Accrued Liabilities, Current

8,943

4,172

3,466

3,678

5,304

2,414

1,388

741

995

688

768

572

1,126

1,005

1,088

582

637

1,036

573

607

380

992

Finance lease obligation, current portion

-

-

-

-

-

5

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

20,608

16,237

14,126

15,295

15,160

11,287

5,662

8,228

10,675

10,457

9,375

9,044

9,558

9,819

9,873

8,918

8,235

6,880

5,824

3,233

3,648

13,355

Build-to-suit obligation, long-term portion, net of debt issuance costs and discount

5,129

6,095

5,907

5,091

4,044

4,478

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, long-term portion

5,618

5,931

6,236

6,369

6,638

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease obligation, long-term portion

-

-

-

-

-

18

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

10

15

20

25

30

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred Rent Credit, Noncurrent

-

-

-

0

0

1,287

1,428

918

716

495

323

127

52

52

51

51

50

45

40

35

30

98

Build-to-suit obligation, long-term portion, net of debt discount

-

-

-

-

-

-

3,265

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Secured promissory note (including accrued interest), net of issuance costs

-

-

-

-

-

-

-

-

-

-

1,948

3,516

5,049

6,550

8,095

9,109

10,522

11,910

13,264

15,077

2,166

2,530

Related party note payable (including accrued interest)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

11,057

10,761

Total liabilities

31,365

28,278

26,289

26,780

25,872

17,070

10,355

9,146

11,391

10,952

11,646

12,687

14,659

16,421

18,019

18,078

18,807

18,835

-

-

-

26,744

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

-

0

-

-

-

0

Common stock, $0.0001 par value; 250,000,000 shares authorized; 54,361,635 and 23,503,214 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

5

2

2

2

1

1

1

1

0

0

4

4

4

0

2

1

1

1

1

1

1

1

Additional paid-in capital

331,475

308,211

300,258

299,023

280,307

279,946

279,584

278,995

233,061

232,922

232,614

232,467

232,285

201,254

200,981

194,109

193,752

193,438

193,154

192,957

192,574

125,062

Accumulated deficit

-307,500

-298,821

-289,881

-280,018

-270,658

-261,232

-251,085

-242,916

-234,080

-225,874

-218,385

-210,512

-203,766

-196,769

-188,974

-181,526

-175,006

-166,891

-159,245

-150,626

-143,047

-138,464

Accumulated other comprehensive loss

-

-

0

0

1

-5

-

-

-

0

-

-2

-

-

-1

-2

-7

-46

-15

-38

-

0

Total stockholders’ equity

23,970

9,392

10,379

19,007

9,651

18,710

28,500

36,080

-1,019

7,048

14,233

21,957

28,523

4,485

12,008

12,582

18,740

26,502

33,895

42,294

49,528

-13,401

Total liabilities and stockholders’ equity

55,335

37,670

36,668

45,787

35,523

35,780

38,855

45,226

10,372

18,000

25,879

34,644

43,182

20,906

30,027

30,660

37,547

45,337

53,023

60,639

66,429

13,343